These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 6713388

  • 1. Immunotherapy with biochemically dissociated fractions of Propionibacterium acnes in a murine ovarian cancer model.
    Berek JS, Cantrell JL, Lichtenstein AK, Hacker NF, Knox RM, Nieberg RK, Poth T, Elashoff RM, Lagasse LD, Zighelboim J.
    Cancer Res; 1984 May; 44(5):1871-5. PubMed ID: 6713388
    [Abstract] [Full Text] [Related]

  • 2. Synergistic effects of combination sequential immunotherapies in a murine ovarian cancer model.
    Berek JS, Lichtenstein AK, Knox RM, Jung TS, Rose TP, Cantrell JL, Zighelboim J.
    Cancer Res; 1985 Sep; 45(9):4215-8. PubMed ID: 4028011
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Role of inflammatory neutrophils in antitumor effects induced by intraperitoneal administration of Corynebacterium parvum in mice.
    Lichtenstein AK, Berek J, Kahle J, Zighelboim J.
    Cancer Res; 1984 Nov; 44(11):5118-23. PubMed ID: 6488171
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Successful immunotherapy with intraperitoneal Corynebacterium parvum in a murine ovarian cancer model is associated with the recruitment of tumor-lytic neutrophils into the peritoneal cavity.
    Lichtenstein AK, Kahle J, Berek J, Zighelboim J.
    J Immunol; 1984 Jul; 133(1):519-26. PubMed ID: 6373934
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of novel adjuvants in specific active immunotherapy.
    Cantrell JL, Finn DJ.
    Prog Clin Biol Res; 1989 Jul; 288():297-307. PubMed ID: 2717639
    [No Abstract] [Full Text] [Related]

  • 10. Action of three species of Propionibacteria (P. granulosum, P. acnes, P. avidum) on experimental tumor systems in mice.
    Roszkowski W, Kobus M, Luczak M, Ko HL, Szmigielski S, Laskowska B, Pulverer G, Jeljaszewicz J.
    Zentralbl Bakteriol A; 1980 Mar; 246(3):405-14. PubMed ID: 6252722
    [Abstract] [Full Text] [Related]

  • 11. IL-2 plasmid therapy of murine ovarian carcinoma inhibits the growth of tumor ascites and alters its cytokine profile.
    Horton HM, Dorigo O, Hernandez P, Anderson D, Berek JS, Parker SE.
    J Immunol; 1999 Dec 15; 163(12):6378-85. PubMed ID: 10586027
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.
    Isayeva T, Ren C, Ponnazhagan S.
    Clin Cancer Res; 2005 Feb 01; 11(3):1342-7. PubMed ID: 15709207
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rejection of murine ovarian cancer following treatment with regional immunotherapy: correlations with a neutrophil-mediated activation of cytostatic macrophages.
    Lichtenstein A.
    Cell Immunol; 1985 Sep 01; 94(2):521-35. PubMed ID: 4028167
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Eradication of ovarian tumor xenografts by locoregional administration of targeted immunotherapy.
    De Cesare M, Calcaterra C, Pratesi G, Gatti L, Zunino F, Mènard S, Balsari A.
    Clin Cancer Res; 2008 Sep 01; 14(17):5512-8. PubMed ID: 18765543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.